Xarelto Lawsuit Plaintiff Alleges Blood Thinning Drug Caused Development Of Life-Threatening Internal Bleed
April 04, 2016 – – BloodThinnerHelp.com reports on details from yet another lawsuit filed against Xarelto manufacturers Janssen Pharmaceuticals (a division of Johnson & Johnson corporation) and Bayer AG. The lawsuit was initially filed in the Eastern District of New York under case number 1:14-cv-04524 before being transferred with thousands of other lawsuits in an MDL consolidation in Eastern Louisiana. The plaintiff involved is a Texas woman who claims that the defendants neglected to properly warn her or other patients regarding potentially dangerous side effects associated with their blood thinner.
Details of the lawsuit documents show that the woman was prescribed Xarelto by her physician in order to prevent stroke or blood clot risks due to her atrial fibrillation condition. This is a common heart condition which generally makes the heart beat more rapidly than usual. The plaintiff had used Xarelto for just 5 months before suffering from a life-threatening internal bleed, which has now left her with long-term medical needs.
Xarelto was approved by the U.S. Food and Drug Administration in 2011 to treat patients recovering from knee and hip replacement surgeries as well as those suffering from pulmonary embolism, deep vein thrombosis, or atrial fibrillation. The agency gave Xarelto two “black box” warnings, which are the most strict warnings a product can receive before being completely pulled from the market.
Within just five years time, Xarelto lawsuits filed from across the United States now number over 3,400 and have been consolidated into two major groupings. Federally-filed lawsuits were consolidated by the U.S. JPML to form MDL number 2592 in Eastern Louisiana and number over 2,800. In addition, over 620 Xarelto lawsuits have been consolidated to form a mass tort program by the Court of Common Pleas in Philadelphia, Pennsylvania.
As involved plaintiffs look forward to 2017 bellwether trials, Attorney Joseph Osborne is working to help others who have used Xarelto and who believe that the drug has caused them health problems. Affected patients may be entitled to substantial compensation attained through legal action. He wishes to ensure that everyone is given the opportunity to evaluate their legal rights in the matter. To help those interested in further exploring their possibilities, Attorney Osborne is currently offering complimentary Xarelto consultations for qualified individuals.
To request additional Xarelto lawsuit information, or to ask questions, please contact Attorney Joseph Osborne by calling (866) 425-8902.
###
Contact BloodThinnerHelp.com:
Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432
ReleaseID: 60009049